Idiopathic Short Stature (ISS) Completed Phase 3 Trials for Somatotropin (DB00052)

Back to Idiopathic Short Stature (ISS)

Also known as: ISS- Idiopathic Short Stature / Short Stature, Idiopathic / Idiopathic Short Stature / Idiopathic short stature (disorder) / Short stature (child) / Short stature / Stature short / Short stature disorder (disorder) / Small stature

Indication	Status	Phase
DBCOND0035250 (Idiopathic Short Stature (ISS))	Completed	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00355030	Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature	Treatment	Leuprolide (DB00007) Somatotropin (DB00052)
NCT01786902	Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature	Treatment	Somatotropin (DB00052)
NCT01778023	Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature	Treatment	Somatotropin (DB00052)
NCT01746862	A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS)	Treatment	Somatotropin (DB00052)
NCT01248416	Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature	Treatment	Anastrozole (DB01217) Letrozole (DB01006) Somatotropin (DB00052)
NCT00396097	Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature	Treatment	Somatotropin (DB00052)
NCT00262249	Effect of Growth Hormone in Children With Growth Hormone Deficiency	Treatment	Somatotropin (DB00052)